343 related articles for article (PubMed ID: 16431394)
1. Effects of tryptophan and valine administration on behavioral pharmacology of haloperidol.
Ali O; Haleem DJ; Saify ZS; Kamil N; Obaid R; Ahmed SW
Pak J Pharm Sci; 2005 Apr; 18(2):23-8. PubMed ID: 16431394
[TBL] [Abstract][Full Text] [Related]
2. Effect of co administration of haloperidol and large neutral amino acids (tryptophan and valine) on rats striatal dopamine, serotonin and their metabolism.
Ali O; Haleem DJ; Obaid R; Kamil N; Haleem MA; Ahmed SW
Pak J Pharm Sci; 2003 Jan; 16(1):13-25. PubMed ID: 16414563
[TBL] [Abstract][Full Text] [Related]
3. Dietary supplementations of amino acids: evidence for enhanced serotonergic functions following haloperidol withdrawal in rat medial prefrontal cortex.
Batool F; Ahmed S; Haleem DJ
J Coll Physicians Surg Pak; 2009 Mar; 19(3):139-45. PubMed ID: 19268010
[TBL] [Abstract][Full Text] [Related]
4. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
Bishnoi M; Chopra K; Kulkarni SK
Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
[TBL] [Abstract][Full Text] [Related]
6. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
Bishnoi M; Kumar A; Chopra K; Kulkarni SK
Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
[TBL] [Abstract][Full Text] [Related]
7. In vivo microdialysis studies of striatal level of neurotransmitters after haloperidol and chlorpromazine administration.
Kulkarni SK; Bishnoi M; Chopra K
Indian J Exp Biol; 2009 Feb; 47(2):91-7. PubMed ID: 19374163
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical changes associated with chronic administration of typical antipsychotics and its relationship with tardive dyskinesia.
Bishnoi M; Chopra K; Kulkarni SK
Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):211-6. PubMed ID: 17520104
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of haloperidol at clinically recommended doses elicits smaller parkinsonian effects but more tardive dyskinesia in rats.
Shireen E; Naeem S; Inam QU; Haleem DJ
Pak J Pharm Sci; 2013 Mar; 26(2):271-6. PubMed ID: 23455196
[TBL] [Abstract][Full Text] [Related]
10. Neurochemical and behavioral effects of m-CPP in a rat model of tardive dyskinesia.
Ikram H; Samad N; Haleem DJ
Pak J Pharm Sci; 2007 Jul; 20(3):188-95. PubMed ID: 17545102
[TBL] [Abstract][Full Text] [Related]
11. Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats.
Haleem DJ; Batool F; Khan NH; Kamil N; Ali O; Saify ZS; Haleem MA
Med Sci Monit; 2002 Sep; 8(9):BR354-61. PubMed ID: 12218936
[TBL] [Abstract][Full Text] [Related]
12. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
[TBL] [Abstract][Full Text] [Related]
13. [Seasonal changes in the behavioral effects of neuroleptics on white rats].
Otter MIa; Kalda EI; Erik IuP
Biull Eksp Biol Med; 1986 Nov; 102(11):577-9. PubMed ID: 2877693
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of rutin, a polyphenolic flavonoid against haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Fundam Clin Pharmacol; 2007 Oct; 21(5):521-9. PubMed ID: 17868205
[TBL] [Abstract][Full Text] [Related]
15. Reversal of haloperidol-induced extrapyramidal symptoms by buspirone: a time-related study.
Haleem DJ; Samad N; Haleem MA
Behav Pharmacol; 2007 Mar; 18(2):147-53. PubMed ID: 17351421
[TBL] [Abstract][Full Text] [Related]
16. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
[TBL] [Abstract][Full Text] [Related]
17. Effect of serotonergic agents on neuroleptic induced catalepsy in rats.
Rao SG; Hrishikeshavan HJ; Guruswami MN
Funct Neurol; 1990; 5(4):353-60. PubMed ID: 1982664
[TBL] [Abstract][Full Text] [Related]
18. Nicotine potentiates the behavioral effects of haloperidol.
Emerich DF; Norman AB; Sanberg PR
Psychopharmacol Bull; 1991; 27(3):385-90. PubMed ID: 1775613
[TBL] [Abstract][Full Text] [Related]
19. Cataleptic activity of the denatured venom of the social wasp Agelaia vicina (Hymenoptera, Vespidae) in Rattus norvegicus (Rodentia, Muridae).
de Oliveira L; Cunha AO; Mortari MR; Coimbra NC; Dos Santos WF
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):198-203. PubMed ID: 16310919
[TBL] [Abstract][Full Text] [Related]
20. A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol.
Umathe SN; Wanjari MM; Manna SS; Jain NS
Neuropeptides; 2009 Jun; 43(3):251-7. PubMed ID: 19403167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
